Using rHuG-CSF in Multiple Myeloma: Consolidated Data, Evolutions, and New Concepts
作者： Pellegrino Musto
DOI: 10.1007/978-3-0348-0218-5_12
关键词:
摘要: The major risk of infection in cancer patients is correlated with duration and severity chemotherapy-induced neutropenia, which depend on several factors, including the underlying disease, patient’s related characteristics, intensity chemotherapy, bone marrow reserve, use hematopoietic growth stem cell dose case transplantation [1, 2].
springer.com
elsevier.com
sci-hub.st 参考文章(63)
Fortunato Morabito, Massimo Gentile, Carla Mazzone, Sara Bringhen, Ernesto Vigna, Eugenio Lucia, Anna G. Recchia, Francesco D. Raimondo, Pellegrino Musto, Antonio Palumbo, Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs European Journal of Haematology. ,vol. 85, pp. 181- 191 ,(2010) , 10.1111/J.1600-0609.2010.01472.X
Grzegorz W. Basak, Ozren Jaksic, Zdenek Koristek, Gabor Mikala, Sandra Basic-Kinda, Jiri Mayer, Tamas Masszi, Sebastian Giebel, Boris Labar, Wieslaw Wiktor-Jedrzejczak, , Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells. European Journal of Haematology. ,vol. 86, pp. 488- 495 ,(2011) , 10.1111/J.1600-0609.2011.01605.X
Enrico Orciuolo, Gabriele Buda, Emerenziana Marturano, Elisa Mauro, Giuseppe Milone, Clotilde Cangialosi, Nicola Di Renzo, Domenico Pastore, Giorgina Specchia, Maria Rosaria De Paolis, Patrizio Mazza, Giuseppe Pietrantuono, Mario Petrini, Lenograstim reduces the incidence of febrile episodes, when compared with filgrastim, in multiple myeloma patients undergoing stem cell mobilization Leukemia Research. ,vol. 35, pp. 899- 903 ,(2011) , 10.1016/J.LEUKRES.2010.10.029
Ingmar Bruns, Ulrich Steidl, Ralf Kronenwett, Roland Fenk, Thorsten Graef, Ulrich-Peter Rohr, Frank Neumann, Johannes Fischer, Christof Scheid, Kai Hübel, Rainer Haas, Guido Kobbe, A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma Transfusion. ,vol. 46, pp. 180- 185 ,(2006) , 10.1111/J.1537-2995.2006.00699.X
Alexandra Carion, Lotfi Benboubker, Olivier Hérault, Françoise Roingeard, Michel Degenne, Delphine Senecal, Isabelle Desbois, Philippe Colombat, Pierre Charbord, Christian Binet, Jorge Domenech, Stromal-derived factor 1 and matrix metalloproteinase 9 levels in bone marrow and peripheral blood of patients mobilized by granulocyte colony-stimulating factor and chemotherapy. Relationship with mobilizing capacity of haematopoietic progenitor cells. British Journal of Haematology. ,vol. 122, pp. 918- 926 ,(2003) , 10.1046/J.1365-2141.2003.04545.X
Takashi Kuwabara, Satoshi Kobayashi, Yuichi Sugiyama, Pharmacokinetics and Pharmacodynamics of a Recombinant Human Granulocyte Colony-Stimulating Factor Drug Metabolism Reviews. ,vol. 28, pp. 625- 658 ,(1996) , 10.3109/03602539608994020
Katharina Gunzer, Bénédicte Clarisse, Stéphanie Lheureux, Corinne Delcambre, Florence Joly, Contribution of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) use in current cancer treatment: review of clinical data. Expert Opinion on Biological Therapy. ,vol. 10, pp. 615- 630 ,(2010) , 10.1517/14712591003689964
Aaron Gerds, Mary Fox-Geiman, Kevin Dawravoo, Tulio Rodriguez, Amir Toor, Scott Smith, Karen Kiley, Donna Fletcher-Gonzalez, Chindo Hicks, Patrick Stiff, Randomized phase III trial of pegfilgrastim versus filgrastim after autologus peripheral blood stem cell transplantation Biology of Blood and Marrow Transplantation. ,vol. 16, pp. 678- 685 ,(2010) , 10.1016/J.BBMT.2009.12.531
A D'Addio, A Curti, N Worel, K Douglas, M R Motta, S Rizzi, E Dan, S Taioli, V Giudice, H Agis, G Kopetzky, R Soutar, B Casadei, M Baccarani, R M Lemoli, The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF Bone Marrow Transplantation. ,vol. 46, pp. 356- 363 ,(2011) , 10.1038/BMT.2010.128
R Ria, T Gasparre, G Mangialardi, A Bruno, G Iodice, A Vacca, F Dammacco, Comparison between filgrastim and lenograstim plus chemotherapy for mobilization of PBPCs Bone Marrow Transplantation. ,vol. 45, pp. 277- 281 ,(2010) , 10.1038/BMT.2009.150